SYNERGY, SOLUTIONS, SUCCESS


 
 

SBIR & STTR Funded Business

Recipient:

NIH SBIR Phase II Grant: 

"Tissue Products and Kits from Renal Disease"

Abstract

STTR Phase I Grant:

"Commercialization of Embryonic Kidney Cell Lines"

Abstract

Home | Products | Services | Resources | Protocols | About Us | FAQ | Links
   

Mission

Contact Probetex Inc.

MODULES

New Products!

Sheep Anti-Thy1 antibody to induce mesangial proliferative glomerulonephritis

Sheep Anti-Fx1A antibody to induce experimental membranous nephritis

Probetex, Inc. is a bio-technology and contract research  organization providing reagents, biological samples, and services for the investigation of experimental models of disease. The company's current focus is on renal diseases, but will soon expand to include liver cardiovascular, and lung diseases.


Company Highlights:   

White Paper & News Releases

Projects:

Chemokine-targeted macrophage depletion ameliorates experimental mesangio-proliferative glomerulonephritis. In partnership with Osprey Pharmaceuticals Limited. Renal Week. San Francisco, CA. November 4, 2007 Abstract     

Molecular mechanisms underlying kidney damage in a rat anti thy-1 model of glomerulonephritis: A Gene expression analysis. J. Am. Soc.Nephrol. 15:435A,2004. In partnership with CuraGen Corporation  Abstract   

Probetex  licenses kidney cell lines: White paper

 

 

      NEW! Kidney cell lines

      Glomerular mesangial

      Glomerular epithelial

      Glomerular endothelial

      Embryonic kidney stem cells

      Please inquire

 

 

 

 

 

 

 

Meetings & Events:

 

 

Visit our Exhibit  Presented at Renal Week 2007!

             


Home
| Products | Services | Resources | Protocols | About Us | FAQ | Links |
Contact Webmaster